-
Ziopharm Oncology Announces $45 Million Warrant Exercise by Existing Shareholders in a Private Placement
Post on 7/29/19
-
Philanthropist Tej Kohli Pledges $2 Million Gift to Champion Biotech Solutions
Post on 7/29/19
-
Karyopharm Therapeutics: Avoid In July 2019
Post on 7/29/19
-
Dynatrace Proposes Terms For U.S. IPO
Post on 7/29/19
-
Ra Pharmaceuticals Closes Public Offering
Post on 7/28/19
-
Chiasma Prices Underwritten Public Offering of $55M of Common Stock
Post on 7/28/19
-
Solid Biosciences Announces $60M Private Placement
Post on 7/28/19
-
Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors
Post on 7/26/19
-
THQ: Buy This Fund Before Healthcare Sector Rebound
Post on 7/26/19
-
Cara Therapeutics Proposes Offering of Common Stock
Post on 7/25/19
-
Verastem Oncology Signs an Exclusive License Agreement with Sanofi
Post on 7/25/19
-
Genocea Provides Corporate Update
Post on 7/25/19
-
Massachusetts General Hospital and ElevateBio Announce a 10-Year Alliance Agreement
Post on 7/25/19
-
Alexion Pharmaceuticals Tops Expectations in Q2
Post on 7/25/19
-
Biogen Raises Guidance as It Looks to the Pipeline for Growth
Post on 7/25/19
-
Mevion and RaySearch Extend Collaboration
Post on 7/24/19
-
Boston Scientific Announces Results For Second Quarter 2019
Post on 7/24/19
-
Thermo Fisher Scientific Reports Second Quarter 2019 Results
Post on 7/24/19
-
Alexion Reports Second Quarter 2019 Results
Post on 7/24/19
-
Biogen Inc. 2019 Q2 - Results - Earnings Call Slides
Post on 7/24/19
-
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q2 2019 Results - Earnings Call Transcript
Post on 7/24/19
-
Is Vertex Pharmaceuticals a Buy?
Post on 7/24/19
-
Ra Pharmaceuticals Prices Public Offering of Common Stock
Post on 7/23/19
-
Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corp.
Post on 7/23/19
-
Blue Cross Blue Shield of Massachusetts Named A Best Place to Work For Disability Inclusion
Post on 7/23/19